Terms: = Pancreatic cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
346 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of the RAF/MEK/ERK Signaling Cascade in pancreatic cancer: Recent Advances and Future Perspectives.
Adamopoulos C; Cave DD; Papavassiliou AG
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
[TBL] [Abstract] [Full Text] [Related]
3. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
4. Radiation-Activated Cobalamin-Kinase Inhibitors for Treatment of pancreatic Ductal Adenocarcinoma.
Gendron LN; Sheveland CG; Gunn JR; Pogue BW; Shell TA; Shell JR
Mol Pharm; 2024 Jan; 21(1):137-142. PubMed ID: 37989273
[TBL] [Abstract] [Full Text] [Related]
5. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer.
Xia L; Nie T; Lu F; Huang L; Shi X; Ren D; Lu J; Li X; Xu T; Cui B; Wang Q; Gao G; Yang Q
Autophagy; 2024 Mar; 20(3):505-524. PubMed ID: 37772772
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based SHP2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of KRAS Mutant cancers.
Hou Q; Jiang W; Li W; Huang C; Yang K; Chen X; Huang M; Shu C; Luo G; Sun H; Chu Q; Wu X
J Med Chem; 2023 Oct; 66(19):13646-13664. PubMed ID: 37754066
[TBL] [Abstract] [Full Text] [Related]
7. src is a target molecule of mannose against pancreatic cancer cells growth in vitro & in vivo.
Xie J; Wu S; Liao W; Ning J; Ding K
Glycobiology; 2023 Oct; 33(10):766-783. PubMed ID: 37658770
[TBL] [Abstract] [Full Text] [Related]
8. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated src/PI3K/Akt signaling pathway.
Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052
[TBL] [Abstract] [Full Text] [Related]
9. EGFR-Induced and c-src-Mediated CD47 Phosphorylation Inhibits TRIM21-Dependent Polyubiquitylation and Degradation of CD47 to Promote Tumor Immune Evasion.
Du L; Su Z; Wang S; Meng Y; Xiao F; Xu D; Li X; Qian X; Lee SB; Lee JH; Lu Z; Lyu J
Adv Sci (Weinh); 2023 Sep; 10(27):e2206380. PubMed ID: 37541303
[TBL] [Abstract] [Full Text] [Related]
10. A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch.
Sun Y; He Q; Li J; Yang Z; Ahmad M; Lin Y; Wu D; Zheng L; Li J; Wang B; Chen C; Hu Y; Luo H; Luo Y
Cell Death Dis; 2023 Jul; 14(7):463. PubMed ID: 37491277
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and Genomic Characterization of pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
[TBL] [Abstract] [Full Text] [Related]
12. Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells.
Xu W; Qadir MMF; Nasteska D; Mota de Sa P; Gorvin CM; Blandino-Rosano M; Evans CR; Ho T; Potapenko E; Veluthakal R; Ashford FB; Bitsi S; Fan J; Bhondeley M; Song K; Sure VN; Sakamuri SSVP; Schiffer L; Beatty W; Wyatt R; Frigo DE; Liu X; Katakam PV; Arlt W; Buck J; Levin LR; Hu T; Kolls J; Burant CF; Tomas A; Merrins MJ; Thurmond DC; Bernal-Mizrachi E; Hodson DJ; Mauvais-Jarvis F
Cell Rep; 2023 May; 42(5):112529. PubMed ID: 37200193
[TBL] [Abstract] [Full Text] [Related]
13. Functional roles of src signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh AR; Ernst M
Oncogene; 2023 Jun; 42(22):1786-1801. PubMed ID: 37120696
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in pancreatic Ductal Adenocarcinoma Microenvironment.
Yin Z; Chen S
Pancreas; 2022 Oct; 51(9):1235-1247. PubMed ID: 37078951
[TBL] [Abstract] [Full Text] [Related]
15. Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through computational approach.
Agrawal S; Das R; Singh AK; Kumar P; Shukla PK; Bhattacharya I; Tripathi AK; Mishra SK; Tiwari KN
Med Oncol; 2023 Apr; 40(5):133. PubMed ID: 37010624
[TBL] [Abstract] [Full Text] [Related]
16. B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin.
Zhou C; Zhu X; Liu N; Dong X; Zhang X; Huang H; Tang Y; Liu S; Hu M; Wang M; Deng X; Li S; Zhang R; Huang Y; Lyu H; Xiao S; Luo S; Ali DW; Michalak M; Chen XZ; Wang Z; Tang J
Signal Transduct Target Ther; 2023 Feb; 8(1):66. PubMed ID: 36797256
[TBL] [Abstract] [Full Text] [Related]
17. Targeting src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
Su L; Chen Y; Huang C; Wu S; Wang X; Zhao X; Xu Q; Sun R; Kong X; Jiang X; Qiu X; Huang X; Wang M; Wong PP
Sci Transl Med; 2023 Jan; 15(678):eabl7895. PubMed ID: 36630483
[TBL] [Abstract] [Full Text] [Related]
18. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal cancers.
Yang YM; Ye L; Ruge F; Fang Z; Ji K; Sanders AJ; Jia S; Hao C; Dou QP; Ji J; Jiang WG
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614319
[TBL] [Abstract] [Full Text] [Related]
19. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract] [Full Text] [Related]
20. Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for pancreatic cancer.
Chen H; Zhou W; Bian A; Zhang Q; Miao Y; Yin X; Ye J; Xu S; Ti C; Sun Z; Zheng J; Chen Y; Liu M; Yi Z
Clin Cancer Res; 2023 Feb; 29(4):815-830. PubMed ID: 36374556
[TBL] [Abstract] [Full Text] [Related]
[Next]
